{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:00Z","timestamp":1786982460909,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12602-023-10040-2","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T02:02:50Z","timestamp":1674007370000},"page":"275-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the Treatment with Akkermansia muciniphila BAA-835 of Chemotherapy-induced Mucositis in Mice"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6079-1196","authenticated-orcid":false,"given":"Ramon O.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-5894","authenticated-orcid":false,"given":"Vivian C.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-7759","authenticated-orcid":false,"given":"M\u00f4nica F.","family":"Quintanilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-4921","authenticated-orcid":false,"given":"Bruno","family":"Gallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1771-5155","authenticated-orcid":false,"given":"Samantha R. M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-1289","authenticated-orcid":false,"given":"Janayne L.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-9853","authenticated-orcid":false,"given":"Jacqueline I.","family":"Alvarez-Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-3033","authenticated-orcid":false,"given":"Lu\u00eds C. L.","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-2280","authenticated-orcid":false,"given":"Vasco","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9094-4843","authenticated-orcid":false,"given":"K\u00e1tia D.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-5187","authenticated-orcid":false,"given":"Simone O. A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-9602","authenticated-orcid":false,"given":"Valbert N.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-0303","authenticated-orcid":false,"given":"Enio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-2608","authenticated-orcid":false,"given":"Jacques R.","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-3062","authenticated-orcid":false,"given":"Flaviano S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"10040_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"10040_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3389\/fphar.2021.681417","volume":"12","author":"D Dahlgren","year":"2021","unstructured":"Dahlgren D, Sj\u00f6blom M, Hellstr\u00f6m PM, Lennern\u00e4s H (2021) Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies. Front Pharmacol 12:1020. https:\/\/doi.org\/10.3389\/fphar.2021.681417","journal-title":"Front Pharmacol"},{"key":"10040_CR3","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:205031212110343. https:\/\/doi.org\/10.1177\/20503121211034366","journal-title":"SAGE Open Med"},{"key":"10040_CR4","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.88325","author":"LCL de Jesus","year":"2019","unstructured":"de Jesus LCL, Lima FA, Coelho-Rocha ND et al (2019) Recombinant probiotics and microbiota modulation as a good therapy for diseases related to the GIT. Heal Benefits Foods - Curr Knowl Furth Dev. https:\/\/doi.org\/10.5772\/INTECHOPEN.88325","journal-title":"Heal Benefits Foods - Curr Knowl Furth Dev"},{"key":"10040_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrc.2017.13","volume":"17","author":"S Roy","year":"2017","unstructured":"Roy S, Trinchieri G (2017) Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 17:271\u2013285. https:\/\/doi.org\/10.1038\/nrc.2017.13","journal-title":"Nat Rev Cancer"},{"key":"10040_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J et al (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14:356\u2013365","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10040_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-019-0679-5","volume":"7","author":"BY Hong","year":"2019","unstructured":"Hong BY, Sobue T, Choquette L et al (2019) Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome 7:66. https:\/\/doi.org\/10.1186\/s40168-019-0679-5","journal-title":"Microbiome"},{"key":"10040_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet MJ, Harmsen HJM, de Bont ESJM, Tissing WJE (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6:1\u20137. https:\/\/doi.org\/10.1371\/journal.ppat.1000879","journal-title":"PLoS Pathog"},{"key":"10040_CR9","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1099\/mic.0.000149","volume":"161","author":"SHSP Pedroso","year":"2015","unstructured":"Pedroso SHSP, Vieira AT, Bastos RW et al (2015) Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiol (UK) 161:1950\u20131960. https:\/\/doi.org\/10.1099\/mic.0.000149","journal-title":"Microbiol (UK)"},{"key":"10040_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MCO.0000000000000487","volume":"21","author":"E Cereda","year":"2018","unstructured":"Cereda E, Caraccia M, Caccialanza R (2018) Probiotics and mucositis. Curr Opin Clin Nutr Metab Care 21:399\u2013404","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10040_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10040_CR12","doi-asserted-by":"publisher","unstructured":"Ka\u017amierczak-Siedlecka K, Skonieczna-\u017bydecka K, Hupp T et al (2022) Next-generation probiotics \u2013 do they open new therapeutic strategies for cancer patients? Gut Microbes 14:2035659. https:\/\/doi.org\/10.1080\/19490976.2022.2035659","DOI":"10.1080\/19490976.2022.2035659"},{"key":"10040_CR13","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2:17057. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.57","journal-title":"Nat Microbiol"},{"key":"10040_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/1040841X.2021.1902940","volume":"47","author":"TP Singh","year":"2021","unstructured":"Singh TP, Natraj BH (2021) Next-generation probiotics: a promising approach towards designing personalized medicine. Crit Rev Microbiol 47:479\u2013498. https:\/\/doi.org\/10.1080\/1040841X.2021.1902940","journal-title":"Crit Rev Microbiol"},{"key":"10040_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3389\/FMICB.2019.01047\/BIBTEX","volume":"10","author":"R Mart\u00edn","year":"2019","unstructured":"Mart\u00edn R, Langella P (2019) Emerging health concepts in the probiotics field: streamlining the definitions. Front Microbiol 10:1047. https:\/\/doi.org\/10.3389\/FMICB.2019.01047\/BIBTEX","journal-title":"Front Microbiol"},{"key":"10040_CR16","doi-asserted-by":"publisher","unstructured":"Schoch CL, Ciufo S, Domrachev M et al (2020) NCBI taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford) 2020:baaa062. https:\/\/doi.org\/10.1093\/database\/baaa062","DOI":"10.1093\/database\/baaa062"},{"key":"10040_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/microorganisms9051098","volume":"9","author":"JN Abuqwider","year":"2021","unstructured":"Abuqwider JN, Mauriello G, Altamimi M (2021) Akkermansia muciniphila, a new generation of beneficial microbiota in modulating obesity: a systematic review. Microorganisms 9:1098. https:\/\/doi.org\/10.3390\/microorganisms9051098","journal-title":"Microorganisms"},{"key":"10040_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.01765","volume":"8","author":"PD Cani","year":"2017","unstructured":"Cani PD, de Vos WM (2017) Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol 8:1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2017.01765","journal-title":"Front Microbiol"},{"key":"10040_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tifs.2021.05.022","volume":"114","author":"PM Reque","year":"2021","unstructured":"Reque PM, Brandelli A (2021) Encapsulation of probiotics and nutraceuticals: applications in functional food industry. Trends Food Sci Technol 114:1\u201310. https:\/\/doi.org\/10.1016\/j.tifs.2021.05.022","journal-title":"Trends Food Sci Technol"},{"key":"10040_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/jam.14911","volume":"130","author":"D Cheng","year":"2021","unstructured":"Cheng D, Xie MZ (2021) A review of a potential and promising probiotic candidate - Akkermansia muciniphila. J Appl Microbiol 130:1813\u20131822. https:\/\/doi.org\/10.1111\/jam.14911","journal-title":"J Appl Microbiol"},{"key":"10040_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/GUTJNL-2014-308778","volume":"65","author":"MC Dao","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J et al (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426\u2013436. https:\/\/doi.org\/10.1136\/GUTJNL-2014-308778","journal-title":"Gut"},{"key":"10040_CR22","doi-asserted-by":"publisher","unstructured":"Kim S, Lee Y, Kim Y et al (2020) Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis. Appl Environ Microbiol 86:e03004\u201391.\u00a0https:\/\/doi.org\/10.1128\/AEM.03004-19","DOI":"10.1128\/AEM.03004-19"},{"key":"10040_CR23","doi-asserted-by":"publisher","unstructured":"Bian X, Wu W, Yang L et al (2019) Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol 10:2259. https:\/\/doi.org\/10.3389\/fmicb.2019.02259","DOI":"10.3389\/fmicb.2019.02259"},{"key":"10040_CR24","doi-asserted-by":"publisher","unstructured":"Zhang J, Ni Y, Qian L et al (2021) Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv Sci 8:e2100536. https:\/\/doi.org\/10.1002\/advs.202100536","DOI":"10.1002\/advs.202100536"},{"key":"10040_CR25","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3389\/FPHAR.2021.725583\/BIBTEX","volume":"12","author":"X Hou","year":"2021","unstructured":"Hou X, Zhang P, Du H et al (2021) Akkermansia muciniphila potentiates the antitumor efficacy of FOLFOX in Colon Cancer. Front Pharmacol 12:2413. https:\/\/doi.org\/10.3389\/FPHAR.2021.725583\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"10040_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2022.04.135","volume":"614","author":"S Chen","year":"2022","unstructured":"Chen S, Qian K, Zhang G, Zhang M (2022) Akkermansia muciniphila and its outer membrane protein Amuc_1100 prophylactically attenuate 5-fluorouracil-induced intestinal mucositis. Biochem Biophys Res Commun 614:34\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.135","journal-title":"Biochem Biophys Res Commun"},{"key":"10040_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/FCIMB.2019.00239\/BIBTEX","volume":"9","author":"R Zhai","year":"2019","unstructured":"Zhai R, Xue X, Zhang L et al (2019) Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol 9:239. https:\/\/doi.org\/10.3389\/FCIMB.2019.00239\/BIBTEX","journal-title":"Front Cell Infect Microbiol"},{"key":"10040_CR28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1099\/IJS.0.02873-0","volume":"54","author":"M Derrien","year":"2004","unstructured":"Derrien M, Vaughan EE, Plugge CM, de Vos WM (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54:1469\u20131476. https:\/\/doi.org\/10.1099\/IJS.0.02873-0","journal-title":"Int J Syst Evol Microbiol"},{"key":"10040_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/S00280-019-03865-8\/FIGURES\/6","volume":"84","author":"BAA Porto","year":"2019","unstructured":"Porto BAA, Monteiro CF, Souza \u00c9LS et al (2019) Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice. Cancer Chemother Pharmacol 84:117\u2013126. https:\/\/doi.org\/10.1007\/S00280-019-03865-8\/FIGURES\/6","journal-title":"Cancer Chemother Pharmacol"},{"key":"10040_CR30","doi-asserted-by":"publisher","unstructured":"de Jesus LCL, Drumond MM, Aburjaile FF et al (2021) Probiogenomics of Lactobacillus delbrueckii subsp. lactis CIDCA 133: in silico, in vitro, and in vivo approaches. Microorganisms 9:829. https:\/\/doi.org\/10.3390\/microorganisms9040829","DOI":"10.3390\/microorganisms9040829"},{"key":"10040_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12602-021-09817-0","volume":"14","author":"JOPA Coutinho","year":"2022","unstructured":"Coutinho JOPA, Quintanilha MF, Campos MRA et al (2022) Antarctic strain of Rhodotorula mucilaginosa UFMGCB 18,377 attenuates mucositis induced by 5-fluorouracil in mice. Probiotics Antimicrob Proteins 14:486\u2013500. https:\/\/doi.org\/10.1007\/s12602-021-09817-0","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10040_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1017\/S0007114520004924","volume":"126","author":"B Gallotti","year":"2021","unstructured":"Gallotti B, Galvao I, Leles G et al (2021) Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model. Br J Nutr 126:853\u2013864. https:\/\/doi.org\/10.1017\/S0007114520004924","journal-title":"Br J Nutr"},{"key":"10040_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/S00203-009-0491-X","volume":"191","author":"FS Martins","year":"2009","unstructured":"Martins FS, Silva AA, Vieira AT et al (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623\u2013630. https:\/\/doi.org\/10.1007\/S00203-009-0491-X","journal-title":"Arch Microbiol"},{"key":"10040_CR34","doi-asserted-by":"publisher","first-page":"1647400","DOI":"10.1080\/20010001.2019.1647400","volume":"9","author":"M Bjorner","year":"2019","unstructured":"Bjorner M, Zhu L (2019) A minimally invasive, low-stress method for serial blood collection in aging mice. Pathobiol Aging Age-related Dis 9:1647400. https:\/\/doi.org\/10.1080\/20010001.2019.1647400","journal-title":"Pathobiol Aging Age-related Dis"},{"key":"10040_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/0148607115581374","volume":"40","author":"MER Andrade","year":"2016","unstructured":"Andrade MER, Dos SRDGC, Soares ADN et al (2016) Pretreatment and treatment with l -arginine attenuate weight loss and bacterial translocation in dextran sulfate sodium colitis. J Parenter Enter Nutr 40:1131\u20131139. https:\/\/doi.org\/10.1177\/0148607115581374","journal-title":"J Parenter Enter Nutr"},{"key":"10040_CR36","doi-asserted-by":"publisher","first-page":"120243","DOI":"10.1016\/j.lfs.2021.120243","volume":"289","author":"MF Quintanilha","year":"2022","unstructured":"Quintanilha MF, Miranda VC, Souza RO et al (2022) Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. Life Sci 289:120243. https:\/\/doi.org\/10.1016\/j.lfs.2021.120243","journal-title":"Life Sci"},{"key":"10040_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00280-008-0715-9","volume":"63","author":"PMG Soares","year":"2008","unstructured":"Soares PMG, Mota JMSC, Gomes AS et al (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63:91\u201398. https:\/\/doi.org\/10.1007\/s00280-008-0715-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"10040_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275. https:\/\/doi.org\/10.1016\/s0021-9258(19)52451-6","journal-title":"J Biol Chem"},{"key":"10040_CR39","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.3390\/IJMS22179347","volume":"22","author":"P Miknevicius","year":"2021","unstructured":"Miknevicius P, Zulpaite R, Leber B et al (2021) The impact of probiotics on intestinal mucositis during chemotherapy for colorectal cancer: a comprehensive review of animal studies. Int J Mol Sci 22:9347. https:\/\/doi.org\/10.3390\/IJMS22179347","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10040_CR40","first-page":"1073","volume":"78","author":"B Kligler","year":"2008","unstructured":"Kligler B, Cohrssen A (2008) Probiotics. Am Fam Physician 78(9):1073\u20131078","journal-title":"Am Fam Physician"},{"key":"10040_CR41","doi-asserted-by":"publisher","first-page":"e0209205","DOI":"10.1371\/journal.pone.0209205","volume":"13","author":"JC Sniffen","year":"2018","unstructured":"Sniffen JC, McFarland LV, Evans CT, Goldstein EJC (2018) Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. PLoS One 13:e0209205. https:\/\/doi.org\/10.1371\/journal.pone.0209205","journal-title":"PLoS One"},{"key":"10040_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbrc.2021.06.018","volume":"566","author":"R Cheng","year":"2021","unstructured":"Cheng R, Xu W, Wang J et al (2021) The outer membrane protein Amuc_1100 of Akkermansia muciniphila alleviates the depression-like behavior of depressed mice induced by chronic stress. Biochem Biophys Res Commun 566:170\u2013176. https:\/\/doi.org\/10.1016\/j.bbrc.2021.06.018","journal-title":"Biochem Biophys Res Commun"},{"key":"10040_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fnut.2021.726108","volume":"8","author":"FL Zhang","year":"2021","unstructured":"Zhang FL, Yang YL, Zhang Z et al (2021) Surface-displayed Amuc_1100 From Akkermansia muciniphila on Lactococcus lactis ZHY1 improves hepatic steatosis and intestinal health in high-fat-fed zebrafish. Front Nutr 8:724. https:\/\/doi.org\/10.3389\/fnut.2021.726108","journal-title":"Front Nutr"},{"key":"10040_CR44","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1039\/D1FO00115A","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Xu W, Wang R et al (2021) The outer membrane protein Amuc_1100 of Akkermansia muciniphila promotes intestinal 5-HT biosynthesis and extracellular availability through TLR2 signalling. Food Funct 12:3597\u20133610. https:\/\/doi.org\/10.1039\/D1FO00115A","journal-title":"Food Funct"},{"key":"10040_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12986-022-00669-1","volume":"19","author":"P Shi","year":"2022","unstructured":"Shi P, Zhao T, Wang W et al (2022) Protective effect of homogeneous polysaccharides of Wuguchong (HPW) on intestinal mucositis induced by 5-fluorouracil in mice. Nutr Metab 19:36. https:\/\/doi.org\/10.1186\/s12986-022-00669-1","journal-title":"Nutr Metab"},{"key":"10040_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","volume":"106","author":"M Derrien","year":"2017","unstructured":"Derrien M, Belzer C, de Vos WM (2017) Akkermansia muciniphila and its role in regulating host functions. Microb Pathog 106:171\u2013181. https:\/\/doi.org\/10.1016\/j.micpath.2016.02.005","journal-title":"Microb Pathog"},{"key":"10040_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2017.10.001","volume":"31","author":"N Ottman","year":"2017","unstructured":"Ottman N, Geerlings SY, Aalvink S et al (2017) Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract Res Clin Gastroenterol 31:637\u2013642. https:\/\/doi.org\/10.1016\/j.bpg.2017.10.001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10040_CR48","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1128\/AEM.01641-16","volume":"82","author":"JP Ouwerkerk","year":"2016","unstructured":"Ouwerkerk JP, van der Ark KCH, Davids M et al (2016) Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl Environ Microbiol 82:6983\u20136993. https:\/\/doi.org\/10.1128\/AEM.01641-16","journal-title":"Appl Environ Microbiol"},{"key":"10040_CR49","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2147\/JIR.S318327","volume":"14","author":"S Yang","year":"2021","unstructured":"Yang S, Yu M (2021) Role of goblet cells in intestinal barrier and mucosal immunity. J Inflamm Res 14:3171\u20133183. https:\/\/doi.org\/10.2147\/JIR.S318327","journal-title":"J Inflamm Res"},{"key":"10040_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1892441","volume":"13","author":"S Kim","year":"2021","unstructured":"Kim S, Shin YC, Kim TY et al (2021) Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. Gut Microbes 13:1\u201320. https:\/\/doi.org\/10.1080\/19490976.2021.1892441","journal-title":"Gut Microbes"},{"key":"10040_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nut.2016.05.003","volume":"33","author":"Y Tang","year":"2017","unstructured":"Tang Y, Wu Y, Huang Z et al (2017) Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil\u2013induced intestinal mucositis and dysbiosis in rats. Nutrition 33:96\u2013104. https:\/\/doi.org\/10.1016\/j.nut.2016.05.003","journal-title":"Nutrition"},{"key":"10040_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","volume":"80","author":"AT Sougiannis","year":"2019","unstructured":"Sougiannis AT, VanderVeen BN, Enos RT et al (2019) Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun 80:44\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.020","journal-title":"Brain Behav Immun"},{"key":"10040_CR53","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1080\/19490976.2020.1765946","volume":"11","author":"Z Menezes-Garcia","year":"2020","unstructured":"Menezes-Garcia Z, Do Nascimento Arifa RD, Ac\u00farcio L et al (2020) Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production. Gut Microbes 11:1531\u20131546. https:\/\/doi.org\/10.1080\/19490976.2020.1765946","journal-title":"Gut Microbes"},{"key":"10040_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/microorganisms9010107","volume":"9","author":"FAL Barroso","year":"2021","unstructured":"Barroso FAL, de Jesus LCL, de Castro CP et al (2021) Intake of Lactobacillus delbrueckii (pExu:hsp65) prevents the inflammation and the disorganization of the intestinal mucosa in a mouse model of mucositis. Microorganisms 9:107. https:\/\/doi.org\/10.3390\/microorganisms9010107","journal-title":"Microorganisms"},{"key":"10040_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/mi.2011.41","volume":"4","author":"NJ Mantis","year":"2011","unstructured":"Mantis NJ, Rol N, Corth\u00e9sy B (2011) Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603\u2013611. https:\/\/doi.org\/10.1038\/mi.2011.41","journal-title":"Mucosal Immunol"},{"key":"10040_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/0148607105029006395","volume":"29","author":"H Nagayoshi","year":"2005","unstructured":"Nagayoshi H, Fukatsu K, Ueno C et al (2005) 5-Fluorouracil infusion reduces gut-associated lymphoid tissue cell number and mucosal immunoglobulin a levels. J Parenter Enter Nutr 29:395\u2013400. https:\/\/doi.org\/10.1177\/0148607105029006395","journal-title":"J Parenter Enter Nutr"},{"key":"10040_CR57","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.biopha.2018.04.133","volume":"103","author":"PAV de Barros","year":"2018","unstructured":"de Barros PAV, Rabelo Andrade ME, de Vasconcelos GS et al (2018) Conjugated linoleic acid prevents damage caused by intestinal mucositis induced by 5-fluorouracil in an experimental model. Biomed Pharmacother 103:1567\u20131576. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.133","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10040_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"44","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) (2004) The pathobiology of mucositis. Nat Rev Cancer 44(4):277\u2013284. https:\/\/doi.org\/10.1038\/nrc1318","journal-title":"Nat Rev Cancer"},{"key":"10040_CR59","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3390\/ijms23094863","volume":"23","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Sangha S, Pan M et al (2022) Oxidative stress and chemoradiation-induced oral mucositis: a scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci 23:4863. https:\/\/doi.org\/10.3390\/ijms23094863","journal-title":"Int J Mol Sci"},{"key":"10040_CR60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/DDDT.S267400","volume":"15","author":"ST Sonis","year":"2021","unstructured":"Sonis ST (2021) Superoxide dismutase as an intervention for radiation therapy-associated toxicities: review and profile of avasopasem manganese as a treatment option for radiation-induced mucositis. Drug Des Devel Ther 15:1021\u20131029. https:\/\/doi.org\/10.2147\/DDDT.S267400","journal-title":"Drug Des Devel Ther"},{"key":"10040_CR61","first-page":"88","volume":"12","author":"H Younus","year":"2018","unstructured":"Younus H (2018) Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim) 12:88\u201393","journal-title":"Int J Health Sci (Qassim)"},{"key":"10040_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/17474124.2019.1595586","volume":"13","author":"G Al-Qadami","year":"2019","unstructured":"Al-Qadami G, Van Sebille Y, Le H, Bowen J (2019) Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis. Expert Rev Gastroenterol Hepatol 13:485\u2013496. https:\/\/doi.org\/10.1080\/17474124.2019.1595586","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10040_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jff.2018.12.027","volume":"53","author":"LCL De Jesus","year":"2019","unstructured":"De Jesus LCL, Drumond MM, de Carvalho A et al (2019) Protective effect of Lactobacillus delbrueckii subsp. Lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis. J Funct Foods 53:197\u2013207. https:\/\/doi.org\/10.1016\/j.jff.2018.12.027","journal-title":"J Funct Foods"},{"key":"10040_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10194444","volume":"10","author":"I Homa-mlak","year":"2021","unstructured":"Homa-mlak I, Brzozowska A, Mlak R et al (2021) Neutrophil-to-lymphocyte ratio as a factor predicting radiotherapy induced oral mucositis in head neck cancer patients treated with radiotherapy. J Clin Med 10:10. https:\/\/doi.org\/10.3390\/jcm10194444","journal-title":"J Clin Med"},{"key":"10040_CR65","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fmicb.2020.01662","volume":"11","author":"S Binda","year":"2020","unstructured":"Binda S, Hill C, Johansen E et al (2020) Criteria to qualify microorganisms as \u201cprobiotic\u201d in foods and dietary supplements. Front Microbiol 11:1662. https:\/\/doi.org\/10.3389\/fmicb.2020.01662","journal-title":"Front Microbiol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-023-10040-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T05:33:18Z","timestamp":1707283998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-023-10040-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10040"],"URL":"https:\/\/doi.org\/10.1007\/s12602-023-10040-2","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"5 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were carried out according to the National Council for the Control of Animal Experimentation (CONCEA). The Ethics Committee in Animal Experimentation (CEUA) from UFMG approved the study (CEUA\/UFMG, Protocol no. 35\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}